Print
Email
Print Edition StoriesTuesday, January 3, 2012
VelQuest acquired by Accelrys for $35M
By Galen Moore, Boston Business Journal
Accelrys Inc. (Nasdaq: ACCL) has acquired VelQuest Corp., a privately held company in Hopkinton that produces software for FDA-regulated industries such as pharmaceuticals and biotech.
The deal was worth $35 million cash, according to a news release issued by Accelrys on Tuesday morning.
Founded in 1999, VelQuest had raised venture capital in the amount of $9.2 million in 2000, in a round led by MedEquity Investors and Chase Capital Partners, the Boston Business Journal reported at the time. Additional investors included BancBoston Ventures, GE Capital Commercial Finance’s health care group and an associate of North Bay Associates.
San Diego-based Accelrys is a scientific enterprise R&D software and services company.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
